(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 8.26% is not forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 13.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.17%.
Cognex's revenue in 2026 is $1,125,425,000.On average, 24 Wall Street analysts forecast CGNX's revenue for 2026 to be $198,012,598,560, with the lowest CGNX revenue forecast at $188,078,293,020, and the highest CGNX revenue forecast at $205,589,611,260. On average, 24 Wall Street analysts forecast CGNX's revenue for 2027 to be $219,901,746,360, with the lowest CGNX revenue forecast at $204,242,586,780, and the highest CGNX revenue forecast at $246,168,723,720.
In 2028, CGNX is forecast to generate $240,107,113,560 in revenue, with the lowest revenue forecast at $220,070,124,420 and the highest revenue forecast at $275,634,884,220.